how to prevent pancreatitis while on semaglutide Reconciling GLP-1s and 🩺 Pancreatitis — Diet &

Description

For autoimmune patients, particularly those with Hashimoto's, this approach can trigger acute inflammatory responses that worsen the very symptoms the medication is meant to address

has significantly raised public awareness and demand for products like Ozempic and Wegovy

The body releases stress hormones, especially cortisol, which affects many bodily systems during substantial weight reduction [3]

Key Takeaways Gastrointestinal events are the most common adverse effects: Nausea, diarrhea, and vomiting were reported in 4067% of participants at higher doses in published Phase 2 trial data Adverse events are dose-dependent: Higher retatrutide doses consistently produced higher rates of GI events across all published trials Most adverse events were mild to moderate: The Phase 2 trial reported the majority of events as Grade 1-2 in severity Discontinuation rates ranged from 610%: Published data shows dropout rates due to adverse events were comparable to other GLP-1 class compounds Retatrutide is not FDA-approved: All safety data comes from investigational clinical trials it remains a research compound What Clinical Trials Tell Us About Retatrutide Adverse Events Retatrutide (LY3437943) is an investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously